English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
Nicholas Gueguen
| Jun 30, 2017
Shire study sees reduction in hereditary angioedema episodes using lanadelumab
Ruth de Jauregui
| May 3, 2017
Study indicates one bleeding incident every 3-15 seconds among hemophiliacs
Robert Hadley
| Apr 28, 2017
Shire’s hashtag campaign focusing on primary immunodeficiency
Keri Carbaugh
| Feb 6, 2017
Shire takes lead on rare conditions, CEO says
Keri Carbaugh
| Jan 18, 2017
Shire again offers scholarship for students with ADHD
Amanda Rupp
| Jun 11, 2016
Shire shareholders approve Baxalta merger
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp
| Apr 17, 2016
Shire sends application to FDA for chewable Vyvanse tablets
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
American Lung Association launches campaign for World Bronchiectasis Day
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
Cipla leads record team at LUNG FORCE Walk NYC supporting lung health
